Prosecution Insights
Last updated: November 04, 2026
Application No. 18/590,480

PHOTOINITIATORS, PHOTOHARDENABLE COMPOSITIONS, AND METHODS FOR FORMING AN OBJECT IN A VOLUME

Non-Final OA §102§103§DP
Filed
Feb 28, 2024
Priority
Aug 31, 2021 — provisional 63/239,360 +1 more
Examiner
ANGEBRANNDT, MARTIN J
Art Unit
1737
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Quadratic 3D Inc.
OA Round
1 (Non-Final)
56%
Grant Probability
Moderate
1-2
OA Rounds
5m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 56% of resolved cases
56%
Career Allowance Rate
770 granted / 1387 resolved
-9.5% vs TC avg
Strong +34% interview lift
Without
With
+34.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
61 currently pending
Career history
1474
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
44.4%
+4.4% vs TC avg
§102
21.1%
-18.9% vs TC avg
§112
20.5%
-19.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1387 resolved cases

Office Action

§102 §103 §DP
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Restriction to one of the following inventions is required under 35 U.S.C. 121: I. Claims 1-5,8,9,12,15,21,47,48,51,53,56,57,59, drawn to a photoswitchable photoinitiator and compositions including it, classified in G03F7/028. II. Claims 30 and 74-76, drawn to processes of exposing photocurable composition including a photoswitchable photoinitiator using two different wavelengths., classified in G03F7/213. The inventions are independent or distinct, each from the other because: Inventions group I and group II are related as product and process of use. The inventions can be shown to be distinct if either or both of the following can be shown: (1) the process for using the product as claimed can be practiced with another materially different product or (2) the product as claimed can be used in a materially different process of using that product. See MPEP § 806.05(h). In the instant case the photoswitchable photoinitiator can be exposed to a single wavelength (for research/evaluation purposes) and/or the compositions can be thermally cured. Restriction for examination purposes as indicated is proper because all the inventions listed in this action are independent or distinct for the reasons given above and there would be a serious search and/or examination burden if restriction were not required because one or more of the following reasons apply: The groups have acquired as separate status in the art as evidenced by their different classification and divergent subject matter. Applicant is advised that the reply to this requirement to be complete must include (i) an election of an invention to be examined even though the requirement may be traversed (37 CFR 1.143) and (ii) identification of the claims encompassing the elected invention. The election of an invention may be made with or without traverse. To reserve a right to petition, the election must be made with traverse. If the reply does not distinctly and specifically point out supposed errors in the restriction requirement, the election shall be treated as an election without traverse. Traversal must be presented at the time of election in order to be considered timely. Failure to timely traverse the requirement will result in the loss of right to petition under 37 CFR 1.144. If claims are added after the election, applicant must indicate which of these claims are readable upon the elected invention. Should applicant traverse on the ground that the inventions are not patentably distinct, applicant should submit evidence or identify such evidence now of record showing the inventions to be obvious variants or clearly admit on the record that this is the case. In either instance, if the examiner finds one of the inventions unpatentable over the prior art, the evidence or admission may be used in a rejection under 35 U.S.C. 103 or pre-AIA 35 U.S.C. 103(a) of the other invention. During a telephone conversation with Martha Ann Finnegan (31,453) on September 22, 2026, a provisional election was made without traverse to prosecute the invention of group I, claims 1-5,8,9,12,15,18,21,47,48,51,53,56,57 and 59. Affirmation of this election must be made by applicant in replying to this Office action. Claims 30 and 74-76 are withdrawn from further consideration by the examiner, 37 CFR 1.142(b), as being drawn to a non-elected invention. Applicant is reminded that upon the cancelation of claims to a non-elected invention, the inventorship must be corrected in compliance with 37 CFR 1.48(a) if one or more of the currently named inventors is no longer an inventor of at least one claim remaining in the application. A request to correct inventorship under 37 CFR 1.48(a) must be accompanied by an application data sheet in accordance with 37 CFR 1.76 that identifies each inventor by his or her legal name and by the processing fee required under 37 CFR 1.17(i). The examiner has required restriction between product or apparatus claims and process claims. Where applicant elects claims directed to the product/apparatus, and all product/apparatus claims are subsequently found allowable, withdrawn process claims that include all the limitations of the allowable product/apparatus claims should be considered for rejoinder. All claims directed to a nonelected process invention must include all the limitations of an allowable product/apparatus claim for that process invention to be rejoined. In the event of rejoinder, the requirement for restriction between the product/apparatus claims and the rejoined process claims will be withdrawn, and the rejoined process claims will be fully examined for patentability in accordance with 37 CFR 1.104. Thus, to be allowable, the rejoined claims must meet all criteria for patentability including the requirements of 35 U.S.C. 101, 102, 103 and 112. Until all claims to the elected product/apparatus are found allowable, an otherwise proper restriction requirement between product/apparatus claims and process claims may be maintained. Withdrawn process claims that are not commensurate in scope with an allowable product/apparatus claim will not be rejoined. See MPEP § 821.04. Additionally, in order for rejoinder to occur, applicant is advised that the process claims should be amended during prosecution to require the limitations of the product/apparatus claims. Failure to do so may result in no rejoinder. Further, note that the prohibition against double patenting rejections of 35 U.S.C. 121 does not apply where the restriction requirement is withdrawn by the examiner before the patent issues. See MPEP § 804.01. In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 47 and 48 are rejected under 35 U.S.C. 102(a)(1) as being fully anticipated by Tomasulo et al., “Synthesis and properties of benzophenone-spiropyran and naphthalene-spiropyran conjugates”, J. Org. Chem. Vol. 72 pp 595-605 (2007) Tomasulo et al., “Synthesis and properties of benzophenone-spiropyran and naphthalene-spiropyran conjugates”, J. Org. Chem. Vol. 72 pp 595-605 (2007) (cited 12/1/2025) teaches the compound SP5 PNG media_image1.png 165 306 media_image1.png Greyscale on page 597 and SP-7 on page 598. PNG media_image2.png 198 298 media_image2.png Greyscale . Claims 1,8,9,12,15,47 and 48 are rejected under 35 U.S.C. 102(a)(1) as being fully anticipated by Regehly et al., “Xolography for linear volumetric 3D printing”, Nature Vol. 588 pp 620+ (12/2020). Regehly et al., “Xolography for linear volumetric 3D printing”, Nature Vol. 588 pp 620+ (12/2020) (cited by applicant 12/1/2025) exemplifies compound DCPI. (page 621) PNG media_image3.png 166 503 media_image3.png Greyscale . This is used in a photopolymerizable composition which includes a monomer (PETA or UDMA/hydroxyethylmethacrylate) and a co-initiator (triethanolamine or N-methyldiethanolamine) where it ius used in a 3D printer assembly (methods section, page 625 ?) The examiner has interpreted the scope of the switchable photoinitiator to include where the Z-C=O)-Z’ is bonded in two carbons of the pyran rings of the spiro pyran compound. The non-Newtonian fluid limitation is considered met by the claims as the composition changes viscosity upon irradiation Claims 1,8,9,12,15,47 and 48 are rejected under 35 U.S.C. 102(a)(1) as being fully anticipated by Garmhausen et al. WO 2021089090. Garmhausen et al. WO 2021089090 (machine translation attached) teaches the composition PNG media_image4.png 330 421 media_image4.png Greyscale Claims 1,8,9,12,15,47 and 48 are rejected under 35 U.S.C. 102(a)(1) as being fully anticipated by Garmshausen et al. WO 2020245456. Garmshausen et al. WO 2020245456 exemplifies switchable photoinitiators on pages 28-38 including PNG media_image5.png 117 178 media_image5.png Greyscale PNG media_image6.png 103 154 media_image6.png Greyscale PNG media_image7.png 90 165 media_image7.png Greyscale PNG media_image8.png 118 154 media_image8.png Greyscale PNG media_image9.png 85 158 media_image9.png Greyscale PNG media_image10.png 146 227 media_image10.png Greyscale Some of the disclosed switchable photoinitiators are combined with monomers and co-initiators in examples formulations 1-12 (pages 89-92). Claims 1,8,9,12,15,47 and 48 are rejected under 35 U.S.C. 102(a)(1) as being fully anticipated by Kumar 6353102. Kumar 6353102 exemplifies the compound in column 9/line 55. PNG media_image11.png 86 142 media_image11.png Greyscale 2,2-phenyl-5-hydroxy-6-morpholinocarbonyl-2H-naphtho[1,2-b]pyran. This is synthesized in example 4 (15/53-16/6). This is combined with acrylates and thermally cured using AIBN and the photochromic properties evaluated.. (example 7). Claims 47 and 48 are rejected under 35 U.S.C. 102(a)(1) as being fully anticipated by Li et al. CN 109046480. Li et al. CN 1090464480 (machine translation attached) exemplifies the polymer [0039] PNG media_image12.png 184 176 media_image12.png Greyscale which is a co-polymer including N, N-dimethyl acrylamide, spiropyranyl and benzophenone structure units [0038] Claims 47 and 48 are rejected under 35 U.S.C. 102(a)(1) as being fully anticipated by Maurer WO 2010079098 Maurer WO 2010079098 teaches spiropyrans bounded by formula PNG media_image13.png 106 157 media_image13.png Greyscale (page 11-12), including the LF4021 having the substituents PNG media_image14.png 83 488 media_image14.png Greyscale Claims 47,48,51,53,57 and 59 are rejected under 35 U.S.C. 103 as being unpatentable over Li et al. CN 109046480, in view of Lone et al., “Microfluidic preparation of dual stimuli-responsive microparticles and light-directed clustering”, Langmuir Vol. 26(23) pp 17975-17980 (2010) Lone et al., “Microfluidic preparation of dual stimuli-responsive microparticles and light-directed clustering”, Langmuir Vol. 26(23) pp 17975-17980 (2010) teaches a N-isopropylacrylmide-spironaphthoxazine methacryloyl copolymer having the structure. PNG media_image15.png 135 317 media_image15.png Greyscale Spironaphthoxazines and spiropyrans are described as analogous, but replacement of the benzopyran ring with the naphthoxazine ring makes the resulting spiroxazine more resistant to UV exposure (photochromism section, page 17977) It would have been obvious to modify the polymer of Li et al. CN 1090464480 by replacing the spiropyran moiety with a spironaphthoxazine based upon the similarity/analogousness taught in Lone et al., “Microfluidic preparation of dual stimuli-responsive microparticles and light-directed clustering”, Langmuir Vol. 26(23) pp 17975-17980 (2010) with a reasonable expectation of gaining improved resistance to UV exposure. Claims 47,48,51,53,57 and 59 are rejected under 35 U.S.C. 103 as being unpatentable over Maurer WO 2010079098, in view of Taniguchi et al. JP-S62164664 Taniguchi et al. JP-S62164664 discloses spiro(indolino)pyrans bounded by formula (C ) and spiro(indolino)naphthoxazines of formula (E) on page 4. PNG media_image16.png 172 376 media_image16.png Greyscale PNG media_image17.png 170 412 media_image17.png Greyscale the Spironaphthopyran compound denoted by general formula (E) is known as a photochromic compound in which fatigue resistance and color-developing-and-reducing ↑1 (color developing and erasure? ) is especially good (page 4/lower left). For R1 and R2, Alkyl of carbon number 1~10 and R3 are.) The aryloxy machine of carbon number 6~10, the aralkoxy machine of carbon number 7~11, The alkoxy group of carbon number 1~6, the Al Gil machine of carbon number 1~6, a halogen group, A cyano group, the acyl group of carbon number 2~10, the alkoxycarbonyl group of carbon number 2~10, Express the alkoxycarbonyl group of carbon number 2~10, the halogen substitution Alkyl machine of carbon number 1 or 2, and the substitution machine chosen from the nitro group. It may be an integer of O~4, and R3 may be of the same kind, or " may be different species. aX showing the substitution machine with which R4 was chosen from no replacing or the substitution aryl group of no replacing of no replacing of no replacing of carbon number 1~20 or a substitution Al Gil machine, and carbon number 3~10 or a substitution cycloalkyl machine, and carbon number 7~20 or a Replacement aralkyl group, and carbon number 6~14. R4 is an alkyl with carbon number 1~20 (substitution or a Direct alkyl machine)! ; of carbon number 3~10!!! No replacing or the substitution aralkyl group of 'Choko substitution Replacement cycloalkyl base and carbon number 7~2O (page 2, upper right column to lower left column) It would have been obvious to modify the spiropyran LF4021 by replacing the spiropyran moiety with a spironaphthoxazine based upon the similarity/analogousness taught in Taniguchi et al. JP-S62164664 with a reasonable expectation of forming a useful photochromic compound having especially good fatigue resistance and color-developing-and-reducing. Claims 47,48,51,53,57 and 59 are rejected under 35 U.S.C. 103 as being unpatentable over Tomasulo et al., “Synthesis and properties of benzophenone-spiropyran and naphthalene-spiropyran conjugates”, J. Org. Chem. Vol. 72 pp 595-605 (2007), in view of Taniguchi et al. JP-S62164664 It would have been obvious to modify the benzophenone substituted spiropyran of Tomasulo et al., “Synthesis and properties of benzophenone-spiropyran and naphthalene-spiropyran conjugates”, J. Org. Chem. Vol. 72 pp 595-605 (2007) by replacing the spiropyran moiety with a spironaphthoxazine based upon the similarity/analogousness taught in Taniguchi et al. JP-S62164664 with a reasonable expectation of forming a useful photochromic compound having especially good fatigue resistance and color-developing-and-reducing. Claims 1,8,9,12,15 and 47-48 are rejected under 35 U.S.C. 103 as being unpatentable over Garmshausen et al. WO 202024545, in view of either of (Tomasulo et al., “Synthesis and properties of benzophenone-spiropyran and naphthalene-spiropyran conjugates”, J. Org. Chem. Vol. 72 pp 595-605 (2007) or Maurer WO 2010079098) combined with Temel et al. “Photopolymerization and photophysical properties of amine linked benzophenone photoinitiator for free radical polymerization”, J. Photochem. Photobiol. A:Chem., Vol. 219 pp 26-31 (2011). Temel et al. “Photopolymerization and photophysical properties of amine linked benzophenone photoinitiator for free radical polymerization”, J. Photochem. Photobiol. A:Chem., Vol. 219 pp 26-31 (2011) teaches the photogeneration of radicals for polymerization of monomers by benzophenone in the presence of an amine. PNG media_image18.png 272 887 media_image18.png Greyscale It would have been obvious to one skilled in the art to modify the compositions of Garmshausen et al. WO 202024545 which include a benzoyl substituted spiropyran, monomer and co-initiator with a benzophenone substituted spiropyran such as those taught by Tomasulo et al., “Synthesis and properties of benzophenone-spiropyran and naphthalene-spiropyran conjugates”, J. Org. Chem. Vol. 72 pp 595-605 (2007) or Maurer WO 2010079098 with a reasonable expectation of forming a useful sensitized photopolymerizable composition, noting that the spiropyrans of each of Garmshausen et al. WO 202024545, Tomasulo et al., “Synthesis and properties of benzophenone-spiropyran and naphthalene-spiropyran conjugates”, J. Org. Chem. Vol. 72 pp 595-605 (2007) and Maurer WO 2010079098 include a benzophenone moiety. Claims 1-5, 8,9,12,15,18,21,47,48,51,53,57 and 59 are rejected under 35 U.S.C. 103 as being unpatentable over Garmshausen et al. WO 202024545, in view of either of (Tomasulo et al., “Synthesis and properties of benzophenone-spiropyran and naphthalene-spiropyran conjugates”, J. Org. Chem. Vol. 72 pp 595-605 (2007) or Maurer WO 2010079098) combined with Temel et al. “Photopolymerization and photophysical properties of amine linked benzophenone photoinitiator for free radical polymerization”, J. Photochem. Photobiol. A:Chem., Vol. 219 pp 26-31 (2011), further in view of Taniguchi et al. JP-S62164664. In addition to the basis above, it would have been obvious to one skilled in the art to modify the compositions rendered obvious by the combination of Garmshausen et al. WO 202024545 and Temel et al. “Photopolymerization and photophysical properties of amine linked benzophenone photoinitiator for free radical polymerization”, J. Photochem. Photobiol. A:Chem., Vol. 219 pp 26-31 (2011) with either of (Tomasulo et al., “Synthesis and properties of benzophenone-spiropyran and naphthalene-spiropyran conjugates”, J. Org. Chem. Vol. 72 pp 595-605 (2007) or Maurer WO 2010079098) by replacing the spiropyran moiety with a spironaphthoxazine based upon the similarity/analogousness taught in Taniguchi et al. JP-S62164664 with a reasonable expectation of forming a useful photochromic compound having especially good fatigue resistance and color-developing-and-reducing. Claims 47,48,51,53,56,57 and 59 are rejected under 35 U.S.C. 103 as being unpatentable over Crano et al. 5021196, in view of Choi et al. 201101985456, Mochizuki et al. 20140029403, Tomasulo et al., “Synthesis and properties of benzophenone-spiropyran and naphthalene-spiropyran conjugates”, J. Org. Chem. Vol. 72 pp 595-605 (2007, Temel et al. “Photopolymerization and photophysical properties of amine linked benzophenone photoinitiator for free radical polymerization”, J. Photochem. Photobiol. A:Chem., Vol. 219 pp 26-31 (2011) and Taniguchi et al. JP-S62164664. Crano et al. 5021196 teaches spiroindolinenaphthopyrans of the formula (III), (in column 10) PNG media_image19.png 105 285 media_image19.png Greyscale R.sub.1 is selected from the group consisting of C.sub.1 -C.sub.8 alkyl, e.g., methyl, ethyl, propyl, butyl, etc., phenyl, phen(C.sub.1 -C.sub.4)alkyl, e.g., benzyl, naphth(C.sub.1 -C.sub.4)alkyl, e.g., 1-naphthylmethyl, allyl, acrylyl(C.sub.2 -C.sub.6)alkyl, methacrylyl(C.sub.2 -C.sub.6)alkyl, carboxy(C.sub.2 -C.sub.6)alkyl, e.g., .beta.-carboxyethyl, .gamma.-carboxypropyl and .delta.-carboxybutyl, cyano(C.sub.2 -C.sub.6)alkyl, e.g., .beta.-cyanoethyl, .gamma.-cyanopropyl, .beta.-cyanoisopropyl, and .delta.-cyanobutyl, C.sub.1 -C.sub.4 acyloxy(C.sub.2 -C.sub.6)alkyl, i.e., [R.sub.c C(O)OR.sub.d --, wherein R.sub.c is a C.sub.1 -C.sub.4 alkyl and R.sub.d is a C.sub.2 -C.sub.6 alkyl], e.g., acetoxyethyl, acetoxypropyl, propionyloxyethyl, acetoxybutyl, and propionyloxypropyl, hydroxy(C.sub.2 -C.sub.6)alkyl, e.g., hydroxyethyl, hydroxypropyl and hydroxybutyl, (C.sub.2 H.sub.4 O).sub.m CH.sub.3, wherein m is a number of from 1 to 6, and mono- and di-substituted phenyl, said phenyl substituents being selected from C.sub.1 -C.sub.4 alkyl and C.sub. 1 -C.sub.5 alkoxy, e.g. methoxy, ethoxy, propoxy, butoxy and pentoxy. Preferably, R.sub.1 is selected from the group consisting of C.sub.1 -C.sub.4 alkyl, phenyl, benzyl, 1-naphth(C.sub.1 -C.sub.2)alkyl, such as 1-naphthylmethyl, carboxy(C.sub.2 -C.sub.4)alkyl, cyano(C.sub.2 -C.sub.4)alkyl, C.sub.1 -C.sub.4 acyloxy(C.sub.2 -C.sub.4)alkyl, e.g., C.sub.1 -C.sub.4 acyloxyethyl, hydroxy- (C.sub.2 -C.sub.4)alkyl and (C.sub.2 H.sub.4 O).sub.m CH.sub.3, wherein m is a number of from 1 to 3, e.g., 2. R.sub.2 and R.sub.3 of formula I are each selected from the group consisting of C.sub.1 -C.sub.5 alkyl, phenyl, mono- and di-substituted phenyl, benzyl, or R.sub.2 and R.sub.3 may combine to form a cyclic ring selected from the group consisting of an alicyclic ring containing from 6 to 8 carbon atoms (including the spiro carbon atom), norbornyl and adamantyl. The aforesaid phenyl substituents may be selected from C.sub.1 -C.sub.4 alkyl and C.sub.1 -C.sub.5 alkoxy radicals. More particularly, R.sub.2 and R.sub.3 are each selected from C.sub.1 -C.sub.5 alkyl, e.g., methyl, ethyl, propyl, butyl and pentyl, and phenyl. When one of R.sub.2 or R.sub.3 is a tertiary alkyl radical, such as tertiary butyl or tertiary amyl, the other is preferably an alkyl radical other than a tertiary alkyl radical (6/50-7/27) R".sub.4 in graphic formula III may be selected from the group consisting of halogen, e.g., chloro, fluoro or bromo, C.sub.1 -C.sub.5 alkyl, C.sub.1 -C.sub.5 alkoxy, e.g., methoxy, ethoxy, propoxy, butoxy and pentoxy, nitro, cyano, thiocyano, C.sub.1 -C.sub.4 monohaloalkyl, e.g., C.sub.1 -C.sub.4 monochloroalkyl, such as chloromethyl and chloroethyl, C.sub.1 -C.sub.2 polyhaloalkyl, as for example, trihaloalkyl, such as trichloroalkyl or trifluoroalkyl, e.g., trifluoromethyl and 2,2,2-trifluoroethyl, and monoalkylamino or dialkylamino, wherein the alkyl moiety of the alkylamino group contains from 1 to 4 carbon atoms, e.g., methylamino, ethylamino, propylamino, dimethylamino and diethylamino. More particularly, the R".sub.4 substituent may be selected from the group C.sub.1 -C.sub.2 alkyl, C.sub.1 -C.sub.2 alkoxy, chloro, fluoro, bromo, nitro and trifluoromethyl. The letter "e" in graphic formula III is a number from 0 to 2, e.g., 1 or 2, and denotes the number of non-hydrogen substituents. When "e" is 0, all of the substituents on the available carbon atoms of the naphtho moiety of the molecule represented by formula III are hydrogen (10/5-55) Choi et al. 20110198546 teaches the reaction of a brominated spiroindolinenaphthopyran with 1,4-phenylenediboronic acid at the site of bromination (page 12 and [0093]. PNG media_image20.png 256 617 media_image20.png Greyscale Mochizuki et al. 20140029403 teaches the reaction of 4-Benzoylphenylboronic acid with a brominated compound 1. PNG media_image21.png 148 213 media_image21.png Greyscale PNG media_image22.png 142 196 media_image22.png Greyscale to functionalize it with a benzophenone group. It would have been obvious to synthesize a spiroindolinenaphthopyrans of the formula (III) which is substituted by bromine in the 8’ position based upon the disclosure of bromine as a substituent for R”4 in column 10 of Crano et al. 5021196 and then to react this with 4-Benzoylphenylboronic acid taught by Mochizuki et al. 20140029403 to functionalize it with a benzophenone group at the 8’ position to add the free radical generation capability taught by Temel et al. “Photopolymerization and photophysical properties of amine linked benzophenone photoinitiator for free radical polymerization”, J. Photochem. Photobiol. A:Chem., Vol. 219 pp 26-31 (2011) which is desirable in spirooxizine compounds as evidenced by Tomasulo et al., “Synthesis and properties of benzophenone-spiropyran and naphthalene-spiropyran conjugates”, J. Org. Chem. Vol. 72 pp 595-605 (20070 with a reasonable expectation of success based upon the prior use of this reaction to functionalize brominated spiroindolinenaphthopyrans as evidenced in Choi et al. 20110198546 to yield a useful photochromic compound having especially good fatigue resistance and color-developing-and-reducing as taught by Taniguchi et al. JP-S62164664 The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1,8,9,12,15 and 47-48 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-11 of U.S. Patent No. 12552761. Although the claims at issue are not identical, they are not patentably distinct from each other because the cited claims of the instant application and claims 1 and 6-10 all describe a photoswitchable photoinitiator which is functionalized by a di(het)aryl ketone, including specific mention of benzophenone. The recitation of coinitiators and photopolymerizable/photohardenable materials is also found in the claims of the instant application and the patent. The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Feiler et al. WO 2009141237 see table on pages 7-9. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Martin J Angebranndt whose telephone number is (571)272-1378. The examiner can normally be reached 7-3:30 pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Ching-Yu (Coris) Fung can be reached at 571-270-5713. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. MARTIN J. ANGEBRANNDT Primary Examiner Art Unit 1737 /MARTIN J ANGEBRANNDT/Primary Examiner, Art Unit 1737 September 22, 2026
Read full office action

Prosecution Timeline

Feb 28, 2024
Application Filed
Sep 24, 2026
Non-Final Rejection mailed — §102, §103, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12782811
DUAL CATALYST SYSTEM FOR MASS ROMP AND CATIONIC POLYMERIZABLE COMPOSITIONS
3y 8m to grant Granted Nov 03, 2026
Patent 12775213
MATERIALS AND METHODS FOR FORMING RESIST BOTTOM LAYER
3y 3m to grant Granted Oct 27, 2026
Patent 12769200
PELLICLE FOR AN EUV LITHOGRAPHY MASK AND A METHOD OF MANUFACTURING THEREOF
2y 3m to grant Granted Oct 20, 2026
Patent 12761561
BOTTOM ANTIREFLECTIVE COATING MATERIALS
3y 2m to grant Granted Oct 13, 2026
Patent 12754481
HARDMASK COMPOSITION, HARDMASK LAYER, AND PATTERN FORMING METHOD
4y 6m to grant Granted Oct 06, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
56%
Grant Probability
90%
With Interview (+34.1%)
3y 1m (~5m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1387 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month